AMAb91409

antibody from Atlas Antibodies

Targeting: TBX19 dj747L4.1, TPIT

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

AMAb91409

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#AMAb91409, RRID:AB_2716678

Product name

Anti-TBX19

Antibody type

Monoclonal

Description

Monoclonal Antibody against Human TBX19, Clone ID: CL6251, Gene description: T-box 19, Alternative Gene Names: dj747L4.1, TPIT, T-PIT, Validated applications: IHC, Uniprot ID: O60806, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

CL6251

Vial size

100 µl

Concentration

1.0 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors.

Jotanovic J, Tebani A, Hekmati N, Sivertsson Å, Lindskog C, Uhlèn M, Gudjonsson O, Tsatsaris E, Engström BE, Wikström J, Pontén F, Casar-Borota O
Journal of the Endocrine Society 2024 Mar 12;8(5):bvae040

---

Genome-Wide DNA Methylation Profiling as a Prognostic Marker in Pituitary Adenomas-A Pilot Study.

Møller MW, Andersen MS, Halle B, Pedersen CB, Boldt HB, Tan Q, Jurmeister PS, Herrgott GA, Castro AV, Petersen JK, Poulsen FR
Cancers 2024 Jun 13;16(12)

---

Pituitary neuroendocrine tumors with PIT1/SF1 co-expression show distinct clinicopathological and molecular features.

Dottermusch M, Ryba A, Ricklefs FL, Flitsch J, Schmid S, Glatzel M, Saeger W, Neumann JE, Schüller U
Acta neuropathologica 2024 Jan 16;147(1):16

---

ACTH-secreting pituitary carcinoma with TP53, NF1, ATRX and PTEN mutations Case report and review of the literature.

Sumislawski P, Rotermund R, Klose S, Lautenbach A, Wefers AK, Soltwedel C, Mohammadi B, Jacobsen F, Mawrin C, Flitsch J, Saeger W
Endocrine 2022 Apr;76(1):228-236

---

Primary Pituitary Adenoid Cystic Carcinoma: A Rare Salivary Gland-Like Tumor in the Sella

Sakata K, Ono T, Koga M, Kikuchi J, Komaki S, Akiba J, Ogo E, Sugita Y, Umeno H, Morioka M
Head and Neck Pathology 2021;15(4):1289-1298

---

Clinical Relevance of New World Health Organization Classification System for Pituitary Adenomas: A Validation Study With 2-Year Experience.

Hong SW, Kim SH, Lim SH, Lee EJ, Kim SH, Ku CR, Kim EH
Frontiers in oncology 2021;11:739290

---

Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations.

Casar-Borota O, Boldt HB, Engström BE, Andersen MS, Baussart B, Bengtsson D, Berinder K, Ekman B, Feldt-Rasmussen U, Höybye C, Jørgensen JOL, Kolnes AJ, Korbonits M, Rasmussen ÅK, Lindsay JR, Loughrey PB, Maiter D, Manojlovic-Gacic E, Pahnke J, Poliani PL, Popovic V, Ragnarsson O, Schalin-Jäntti C, Scheie D, Tóth M, Villa C, Wirenfeldt M, Kunicki J, Burman P
The Journal of clinical endocrinology and metabolism 2021 Mar 25;106(4):1183-1194

---

Pituitary Gangliocytoma Producing TSH and TRH: A Review of “Gangliocytomas of the Sellar Region”

Sakata K, Fujimori K, Komaki S, Furuta T, Sugita Y, Ashida K, Nomura M, Morioka M
The Journal of Clinical Endocrinology & Metabolism 2020;105(10):3109-3121